Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Statement [Abstract]        
Revenues $ 0 $ 0 $ 0 $ 0
Costs and Expenses        
Operating expenses 413,000 655,000 945,000 1,133,000
Research and development expenses 157,000 432,000 227,000 583,000
Loss before other expense (570,000) (1,087,000) (1,172,000) (1,716,000)
Other expense        
Interest and financing expense (271,000) (371,000) (435,000) (2,024,000)
Net loss $ (841,000) $ (1,458,000) $ (1,607,000) $ (3,740,000)
Net loss per common share, basic and diluted $ (0.00) $ (0.00) $ (0.01) $ (0.01)
Weighted average common shares outstanding, basic and diluted 314,950,397 293,284,367 313,007,039 279,658,273